Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Hydroxocobalamin measurement (procedure) |
Has measured component |
False |
Vitamin B>12b< |
Inferred relationship |
Some |
|
Hydroxocobalamin measurement (procedure) |
Component |
False |
Vitamin B>12b< |
Inferred relationship |
Some |
|
krystallinsk hydroxocobalamin-præparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B>12b< |
Inferred relationship |
Some |
|
Product containing hydroxocobalamin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B>12b< |
Inferred relationship |
Some |
|
hydroxocobalamin 1 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B>12b< |
Inferred relationship |
Some |
|
Product containing precisely cyanocobalamin 50 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B>12b< |
Inferred relationship |
Some |
|
Product containing precisely cyanocobalamin 7 microgram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B>12b< |
Inferred relationship |
Some |
|
Product containing cyanocobalamin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B>12b< |
Inferred relationship |
Some |
|
præparat indeholdende B>12<-vitamin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B>12b< |
Inferred relationship |
Some |
|
Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B>12b< |
Inferred relationship |
Some |
|
cyanocobalamin 100 µg/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B>12b< |
Inferred relationship |
Some |
|
hydroxocobalamin 1000 µg/ml injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B>12b< |
Inferred relationship |
Some |
|
cyanocobalamin 100 µg/ml injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B>12b< |
Inferred relationship |
Some |
|
hydroxocobalamin 1000 µg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B>12b< |
Inferred relationship |
Some |
|